ArticleProceedings of the National Academy of Sciences of the United States of America2025
SARS-CoV-2-derived RNA replicons as safe and effective vaccines.
Marta Villarejo-Torres et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.